// App-Quantinova.ai

3858 : Feasibility and efficacy of a precision treatment approach for triple-negative breast cancer in mouse models

Researchers

Presenter

  • Hui Liu

Principal Investigators

  • Charles Murphy

  • Florian Karreth

  • Kangkang Yang

  • Gerburg Wulf

  • Lewis C. Cantley

Medical Centers

  • Harvard Medical School, Boston, MA

  • Weill Cornell Medical College, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • p53

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • I/II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved